Price Alert

Fortress Biotech Inc. (FBIOP)

NASDAQ: FBIOP · Real-Time Price · USD

7.70

0.11 (1.45%)

At close: Aug 21, 2025, 3:56 PM

7.71

0.13%

After-hours: Aug 21, 2025, 04:00 PM EDT

Fortress Biotech Statistics

Share Statistics

Fortress Biotech has 7.56M shares outstanding. The number of shares has increased by -88.12% in one year.

Shares Outstanding	7.56M
Shares Change (YoY)	-88.12%
Shares Change (QoQ)	-6%
Owned by Institutions (%)	0.01%
Shares Floating	5.35M
Failed to Deliver (FTD) Shares	148
FTD / Avg. Volume	1.07%

Short Selling Information

The latest short interest is 131, so 0% of the outstanding shares have been sold short.

Short Interest	131
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1

Valuation Ratios

The PE ratio is -0.92 and the forward PE ratio is -9.26. Fortress Biotech's PEG ratio is 0.01.

PE Ratio	-0.92
Forward PE	-9.26
PS Ratio	0.73
Forward PS	0.5
PB Ratio	1.86
P/FCF Ratio	-0.44
PEG Ratio	0.01

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Fortress Biotech.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.27, with a Debt / Equity ratio of 3.34.

Current Ratio	1.27
Quick Ratio	1.06
Debt / Equity	3.34
Debt / EBITDA	-0.73
Debt / FCF	-0.8
Interest Coverage	-11.12

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$571.04K
Profits Per Employee	$-455.42K
Employee Count	101
Asset Turnover	0.4
Inventory Turnover	1.45

Taxes

Income Tax	312K
Effective Tax Rate	-0.26%

Stock Price Statistics

The stock price has increased by 19.38% in the last 52 weeks. The beta is 1.76, so Fortress Biotech's price volatility has been higher than the market average.

Beta	1.76
52-Week Price Change	19.38%
50-Day Moving Average	7.75
200-Day Moving Average	6.72
Relative Strength Index (RSI)	54.53
Average Volume (20 Days)	13,895

Income Statement

In the last 12 months, Fortress Biotech had revenue of 57.67M and earned -46M in profits. Earnings per share was -2.69.

Revenue	57.67M
Gross Profit	36.8M
Operating Income	-110.38M
Net Income	-46M
EBITDA	-104.49M
EBIT	-108.95M
Earnings Per Share (EPS)	-2.69

Full Income Statement

Balance Sheet

The company has 57.26M in cash and 75.96M in debt, giving a net cash position of -18.7M.

Cash & Cash Equivalents	57.26M
Total Debt	75.96M
Net Cash	-18.7M
Retained Earnings	-740.87M
Total Assets	159.9M
Working Capital	52.88M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -80.19M and capital expenditures -15M, giving a free cash flow of -95.19M.

Operating Cash Flow	-80.19M
Capital Expenditures	-15M
Free Cash Flow	-95.19M
FCF Per Share	-4.58

Full Cash Flow Statement

Margins

Gross margin is 63.8%, with operating and profit margins of -191.38% and -79.75%.

Gross Margin	63.8%
Operating Margin	-191.38%
Pretax Margin	-209%
Profit Margin	-79.75%
EBITDA Margin	-181.17%
EBIT Margin	-191.38%
FCF Margin	-165.05%

Dividends & Yields

FBIOP pays an annual dividend of $2.34, which amounts to a dividend yield of 14.05%.

Dividend Per Share	$2.34
Dividend Yield	14.05%
Dividend Growth (YoY)	0%
Payout Ratio	-271.58%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for FBIOP.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	-7.05
Piotroski F-Score	3